Armonica Technologies is an early stage medtech company focused on developing its proprietary long-read DNA sequencing technology for precision medicine applications. The Company’s technology is based upon a portfolio of patented and patent pending technologies licensed from STC.UNM.

Today’s standard genome sequencing approaches require extensive library preparation and create a massive computational and bioinformatics problem related to reassembling the data set. Armonica’s technology uses proprietary nanochannels to deliver single DNA molecules through nanopores for optical readout by Raman spectroscopy. Armonica’s approach will lead to faster, more thorough, and more accurate genomic analysis than is currently available, without the need for library preparation.